Literature DB >> 7569764

Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism.

J S Scolapio1, M Camilleri, M R von der Ohe, R B Hanson.   

Abstract

BACKGROUND: The role of serotonergic type-3 receptors in proximal human colon is unclear. Our aims were to assess the postprandial volume and emptying of the ascending colon and to explore the role of 5-hydroxytryptamine-3 (5HT3) mechanisms.
METHODS: In healthy subjects with unprepared colons we evaluated in a randomized trial the effects of the 5HT3 antagonist ondansetron (n = 5) or placebo (n = 5) on ascending colon volume and emptying, using a scintigraphic method.
RESULTS: Base-line ascending colon volumes were similar and were unaltered by ondansetron. After a 1000-kcal liquid meal the placebo group showed a variable change in volume (P = NS versus base line) during the first 25 min (median, -4%; range, -13% to 135%). Increases in volume during this period coincided with ileal emptying of chyme. During a second phase (30-105 min) there was a significant decrease of ascending colon volume (P = 0.02) relative to the early postprandial volume, but the volume was not significantly different from base line. This second phase was associated with transfer of chyme towards the transverse colon. In the ondansetron group there was an initial modest increase in volume (median, 5%; range, -15% to 14%; P = NS versus base line), and the second phase of contraction was inhibited.
CONCLUSIONS: The ascending colon response to a meal in health is characterized by a variable initial change in volume, accommodating ileal chyme in some individuals, and a more consistent reduction in volume from 30 to 105 min postprandially. The latter response is inhibited by ondansetron, suggesting partial control of postprandial colonic motor function by 5HT3 mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7569764     DOI: 10.3109/00365529509089790

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

Authors:  Amalia Diakidou; Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

Review 3.  A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Authors:  Zhou Likun; Jing Xiang; Ba Yi; Duan Xin; Zheng Liu Tao
Journal:  Oncologist       Date:  2011-01-31

Review 4.  Advances in colonic drug delivery.

Authors:  Abdul W Basit
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.

Authors:  C P Bearcroft; D Perrett; M J Farthing
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

Review 6.  Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

7.  Postoperative colonic motility after tropisetron and a standardized meal in patients undergoing conventional colorectal surgery.

Authors:  Michael S Kasparek; Joerg Glatzle; Mario H Mueller; Andreas Vogt; Alfred Koenigsrainer; Tilman T Zittel; Martin E Kreis
Journal:  Int J Colorectal Dis       Date:  2006-08-29       Impact factor: 2.796

8.  Drug development for the irritable bowel syndrome: current challenges and future perspectives.

Authors:  Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2013-02-01       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.